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 In this contribution we will show that research in the field of toxicology, pharmacolo-
gy and physiology is by and large characterised by a pendulum swing of which the ampli-
tudes represent risks and benefits of exposure. As toxicology usually tests at higher levels
than the populace routinely is exposed to, it reverts to mostly linear extrapolative models
that express the risks of exposure, irrespective of dosages, only. However, as we will explicate
in two examples, depending on dosages, it is less easy to separate risks and benefits than
current toxicological research and regulatory efforts suggest. The same chemical com-
pound, in the final analysis, is represented within the boundaries of both amplitudes, that
is, show a biphasic, hormetic, dose-response. This is notable, as low-level exposures from
the food-matrix are progressively more under scrutiny as a result of increasing analytical
capabilities. Presence of low-level concentrations of a chemical in food is a regulatory
proxy for human health, but in light of this hormetic dose-response objectionable.
Moreover, given that an ecological threshold probably holds for most, if not all, man-made
(bio)organic chemicals, these will be found to be naturally present in the food matrix.
Both aspects require toxicology to close the gap between reductionist models and its
extrapolative deficiencies and real-life scenarios.
Keywords: Pendulum swing, reductionism, nitrate, chloramphenicol, REACH, hormesis
INTRODUCTION
One of the focal points of toxicology is the improvement of public
health through the implementation of results-based policies. The grow-
ing knowledgebase of toxicology helps to define and direct research and
concomitant public policies. This is the case for chemical- and food-safe-
ty regulations but also environmental policies, to name just three.
Now, with advent of REACH (the European Community Regulation
on Registration, Evaluation, Authorisation and Restriction of Chemical
substances; Regulation (EC) No 1907/2006) the question whether toxi-
cological models –linear in character, extrapolating from high experi-
mental dosages to low ‘everyday life’ exposure ranges and either with or
Address correspondence to Jaap C. Hanekamp,  Lange Noordstraat 1, Middelburg, Zld,
Netherlands NL-4331 CB; Phone: 31(0)625002373; Email: j.hanekamp@roac.nl
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without a threshold; the linear threshold (LT) for non-genotoxic chemi-
cals (B; Fig. 1) and linear non-threshold (LNT) for genotoxic chemicals
(A; Fig. 1), respectively- effectively capture reality is quite an important
one. This question has become all the more pertinent, e.g. considering
societal costs and the return of investments in terms of human health
gained when REACH will be fully implemented. (Rovida and Hartung
2009) In other words, can the reductionist methodologies in toxicology
be effectively adapted to real-world issues?
Obviously, the reductionist conundrum is as old as science itself.
Reductionism is a widely accepted and highly successful practice in sci-
ence, by which wholes are studied through breaking them up into their
constituent parts. However, the success of the strategy does not straight-
forwardly imply that everything relevant to the whole can be studied only
through studying its parts.1
In toxicology reductionism would approximately reason as follows: a
complex system (whole organism) is nothing but the sum of its parts (e.g.
metabolic pathways) whereby a toxicological effect, induced by some
compound at a certain concentration over a certain amount of time
experimentally expressed in vitro or in vivo, is a sufficient indicator for the
whole of the target-organism, e.g. human beings. This reasoning in all its
technical intricacies –e.g. the applied reductionism is multi-facetted as
not only metabolic pathways function as a marker for the whole, but also
one organism stands as a model for another- has, with the advent and
implementation of REACH, gained tremendous societal importance.
J. C. Hanekamp and others
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1 Apart from methodological reductionism there is a second type of reductionism called
conceptual reductionism, in which the concepts applicable to the whole are entirely articulat-
ed in terms of concepts applying to the parts. An example of a successful reduction of this kind
is afforded by the use of the kinetic theory of gases as to accurately reduce the concept of tem-
perature, originating in the thermodynamics of bulk matter, to the average kinetic energy of
the molecules of the gas. 
Nevertheless, there are many examples that clearly suggest that reductions of this kind will
not always be successful. Individual water molecules, for instance, do not possess the property
of what we as humans experience as ‘wetness’. This is a conceptually irreducible aspect of the
behaviour of a multitude of water molecules, which together generate inter-molecular forces
that are the source of the bulk property called surface tension, which is a phenomenon best
illustrated by the water striders (predatory insects that make use of the water’s surface tension
to move about on water). 
A third kind is called ontological reductionism. It implies that the whole is nothing but the
sum of its parts. Study the parts and it will reveal the whole. This type of reductionism is the
most troublesome; it is quite possible to hold to methodological reductionism yet to deny onto-
logical reductionism as, in fact, many scientists do. The overarching conundrum of ontological
reductionism is that it breaks down the distinction between logical and scientific possibilities.
Put differently, methodological reduction, which in any scientific procedure is a normal and
even required routine as to make any research feasible, is expanded beyond its original
research limits erroneously making the evidence retrieved from scientific research to be
regarded as all-encompassing.
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The laudable aim of REACH is to improve upon the protection of
human health and the environment through the better and earlier iden-
tification of the intrinsic (dangerous or not) properties of chemical sub-
stances. At the same time, REACH aims to enhance innovation and com-
petitiveness of the EU chemicals industry. Moreover, the benefits of
REACH will come gradually, as more and more substances are phased
into REACH. Whether these benefits –protection of human health and
the environment and the enhancement of innovation and competitive-
ness of the EU chemicals industry- will measurably bear out in the future,
of course, remains to be seen.
REACH is considered to be one the biggest efforts in regulatory his-
tory (Hartung and Rovinda 2009). Within the developing framework of
REACH, it has become imperative to robustly extrapolate results from
toxicological models to real-life circumstances in terms of exposure-lev-
els, -duration, and, most importantly, -effects. Real-life exposures are usu-
ally the result of acute or routine exposures that are either unavoidable
because of a natural (ecological) presence of chemicals or the result of
industrial activities. The extrapolative strength of existing toxicological
data is assumed without much discussion despite the fact that there are
‘too many rodent carcinogens’ (Ames and Gold 1990), not to mention
the current developments in the field of epigenetics we cannot discuss
here in any detail (See e.g. Trosko and Upham 2005), or indeed the
increasingly important finding of the concept of hormesis (C; Fig. 1;
Calabrese and Baldwin 2003).
Hormesis is usually described as a dose-response relationship that is
characterised as biphasic (an inverse U- or J-shaped curve) with low-dose
Connecting Toxicology and Human Health
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FIGURE 1. Dose response curves. 
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stimulation and high-dose inhibition. A famous example of a biphasic
dose-response is found in the detailed analysis of the US FDA/2-AAF
study by an expert panel of the US Society of Toxicology. It revealed a
hormetic dose response for bladder cancer with risks decreasing below
the control group at low doses. In their own words: ‘If we insist that it is
possible to construct low-dose extrapolations for carcinogens in terms of
increases in overall probability of tumor, then we are forced to use addi-
tive models. In such a case, the ED01 study provides more than evidence
of a “threshold”. It provides statistically significant evidence that low doses
of a carcinogen are beneficial.’ (Bruce et al. 1981)
In this article we probe toxicological modelling and its results in the
understanding of human health at exposure levels that, as a rule, are sub-
stantially lower than experimental results and the fitted models normally
allow for. This problem is far from new, and has been debated almost ad
nauseam. Nevertheless, the implications call for continuous scrutiny of
new regulation as man-made chemical exposure levels amongst the gen-
eral public have, by and large, decreased over the last couple of decades
(see e.g.: LaKind et al. 2004; Boon et al. 2009). This paradoxically is a sit-
uation offset by an increased attention to chemicals exposure and its con-
comitant potential risks in the context of increased regulatory efforts to
further the decrease of environmental exposure of chemicals. Indeed,
Kang and Trosko are quite clear in their précis of the NAS Report Toxicity
testing in the 21st Century: A Vision and a Strategy: ‘Essentially, the report stat-
ed, in unequivocal terms, what was obvious, namely, the current concepts
and testing procedures were not sufficiently adequate for extrapolation
to human beings.’ (Kang-K-S and Trosko 2011)
The issue of extrapolation will be our focus in this contribution. With
the aid of two examples we will outline the challenging relationship
between current toxicological models and human health impacts of
chemical exposures in the light of the regulatory drive to create some sort
of a ‘toxic free society,’2 a society that is to all intents and purposes free
from the burden of man-made chemicals. We will analyse these examples
specifically with the aim to propose a way forward, that is to further the
attempts to robustly connect toxicological research and the potential to
improve upon human health with the aid of its results.
What will be shown is that research in toxicology, pharmacology and
physiology is by and large characterised by a pendulum swing of which
the amplitudes represent risks and benefits of exposure. As toxicology usu-
ally tests at higher levels than to which the populace routinely is exposed
to, decision makers use linear extrapolative models to interpret toxico-
logical results that express the risks of exposure only, irrespective of dosages
greater or equal to zero. However, as we will see in the examples below,
depending on dosages, it is less easy to separate risks and benefits than
current toxicological research and regulatory efforts suggest. The same
J. C. Hanekamp and others
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chemical compound, in the final analysis, is represented within the
boundaries of both amplitudes. This is, of course, a well-known phenom-
enon in pharmacology (Walsh and Schwartz-Bloom 2005, p. 18 and p.
212-213; italics added):
‘The word pharmacology is derived from the Greek pharmakon,
equivalent to ‘drug’, ‘medicine’ or ‘poison’, and logia, meaning ‘study’.
[...] The ideal drug would produce its desired effect –its therapeutically
useful effect- in all biologic systems without inducing any side-effect, i.e.
an effect other than that for which the drug is administered. But there is
no ideal drug. Most drugs produce many effects, and all drugs produce
at least two effects. And it is also a truism that no chemical agent can be
considered entirely safe. For every drug, there is some dose that will pro-
Connecting Toxicology and Human Health
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2 With this remark we refer to the Swedish environmental goals. Since 1968, Sweden has
realised that most of the country’s environmental problems originate from outside its borders
(Sweden is not a major player within the chemical industrial field), and hence to improve the
country’s environment it has to be internationally active. Domestic environmental policies ‘are
increasingly designed with a deliberative view to the possible impact on EU policymaking.”
(Liefferink and Andersen 1998).
In 2000, the Swedish environmental objectives were defined as follows (Summary of Gov.
Bill 2000 / 01:130): ‘The outcomes within a generation for the environmental quality objective
A Non-Toxic Environment should include the following:
• The concentrations of substances that naturally occur in the environment are close to
the background concentrations.
• The levels of foreign substances in the environment are close to zero.
• Overall exposure in the work environment, the external environment and the indoor
environment to particularly dangerous substances is close to zero and, as regards other
chemical substances, to levels that are not harmful to human health.
• Polluted areas have been investigated and cleaned up where necessary.’
Löfstedt sees Sweden’s environmental ambition reflected in EU’s regulation (Löfstedt
2003): ‘In the work building up to the 1992 Rio Conference on sustainable development,
Sweden was one of the most active participants. Because of a Swedish initiative, chemicals
received a separate chapter, largely based on Swedish chemical control policy (the substitution
and precautionary principles). In 1994, the Swedish government organized a conference on
chemicals, which in turn led to the establishment of an Intergovernmental Forum for
Chemical Safety. When Sweden was negotiating its membership in the EU in 1994, Sweden was
granted a four-year transition period during which the EU pledged to review its own legislation
.... In fact, ever since Sweden joined the European Union it has been highly active in pushing
for an international review of chemical policy. Following a Commission meeting in Chester in
1998 and an informal meeting of the Environmental Ministers in Weimar in May 1999, this
objective became a reality.
In the development of the European Commission’s White Paper “Strategy for a Future
Chemicals Policy” (CWP) Swedish regulators took a lead role, promoting, among other things,
the reversed burden of proof requirement (European Commission. 2001. White paper: strate-
gy for a future chemicals policy. European Commission, Brussels). As such, the differences
between this White Paper and the recent Swedish document Non Hazardous Products:
Proposals for Implementation of New Guidelines on Chemicals Policy are hardly discernable.
One of the most important elements of the CWP is that future regulation of chemicals should
be based on hazard, not risk—a prominent feature of Swedish chemical control policy that
argues that chemicals are persistent, bioaccumulative, and should be phased out regardless of
what actual risk they may pose ....’ (See further: Wallström 2008)
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duce a toxic effect—one deleterious to the subject or even life-threaten-
ing. Given the fact that any chemical can be expected to produce toxic
effects, the risks entailed in its use must be weighed against its effective-
ness before it can be considered a salutary agent. The safety of a drug
depends on the degree of separation between the doses producing a desirable effect
and the doses at which adverse effects are elicited.’
Also, the examples show that despite the fact that toxicological mod-
els are incrementally refined in terms of understanding human health
and chemicals exposure, new and innovative insights will always remain
part of the scientific equation, by default excluding the potential to cre-
ate the utopian ‘toxic free society’.
EXAMPLE 1 - NITRATE
Exposure to nitrate and its potential effects on human physiology are
interesting on multiple levels. Firstly, exposure to the nitrate molecule
(NO3
–) is a life-long experience that cannot be evaded, as nitrate is ubiq-
uitous in our food and water. Nitrate is thereby a good ‘model com-
pound’ in the food matrix with an extended scientific knowledgebase
developed over the course of the 20th and 21st century. Secondly, nitrate
is studied not only in experimental models but also at the population
level. This gives insight in how scientists understand the developing
knowledgebase at both ends of the research scale –pharmacology/toxi-
cology and epidemiology- and how both ends do or do not link up.
Thirdly, the developing knowledgebase of nitrate in human physiology
and toxicology has its rendition in rules and regulations. It is interesting
to see whether this regulatory rendition approximates the breadth and
depth of the available and developing knowledgebase.
Obviously, nitrate itself is not the toxicological agent, both in con-
nection to infant methaemoglobinaemia (also known as blue-baby syn-
drome; Comly 1945; Walton 1951)3 and cancer (Mirvish 1995; Vermeer et
al. 1998; Vermeer 2000), the two main risk factors of nitrate exposure that
have scrutinised the most. In the former, nitrite (NO2
-) does the damage
by oxidising the Fe2+ in haemoglobin to Fe3+ whereby the capacity to
transport oxygen is nullified; in the latter nitrite reacts under acidic con-
ditions with amines to form the rodent-carcinogens N-nitrosamines (R2N-
N=O; Magee and Barnes 1956; Gangolli et al. 1994). In general, forma-
tion of nitrite from ingested nitrate is regarded to imply a genotoxic risk
J. C. Hanekamp and others
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3 Haemoglobin, the oxygen-carrying protein that is present in large amounts in red blood
cells, contains iron in its second oxidation state: Fe2+. This haemoglobin is also called ferro-oxy-
haemoglobin. With iron in this oxidation state, haemoglobin is capable of binding and releas-
ing oxygen. Iron oxidised further to Fe3+, resulting in the so-called (ferri) methaemoglobin, is
incapable of binding oxygen and liberating it in organ tissue. Above a certain concentration
level the organism may be harmed by oxygen deficiency. In the most serious cases this leads to
death -occuring at methaemoglobin formation levels of between 45% and 60%.
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as a consequence of endogenous formation of carcinogenic N-nitroso
compounds (NOCs). The stomach is regarded as the in vivo reaction ves-
sel in which most of the NOCs are formed from dietary nitrate and ingest-
ed food.
Nitrate pharmacology, toxicology and physiology are best described
as a pendulum swing. Towards one end of the amplitude, nitrate is shown
to have a long-standing medical track record dating back to the 12th cen-
tury and reaching its zenith in the 19th century (L’hirondel and
L’hirondel 2002). However, in the 20th century the nitrate pendulum
swung the opposite direction when the toxicological profile of nitrate was
pushed on the scene. The risk factors described above still are the focus
of much research in roughly the past half century.
The nitrate limit in water is 50 mg of NO3
-/L in the EU and 44 mg/L
in the USA. These limits are in conformity with WHO recommendations
established in 1970 and recently reviewed and reconfirmed in 2008
(WHO 2008). The limits were originally set, and remain so, on the basis
of acute human health concerns: ‘50 mg/litre to protect against
methaemoglobinaemia in bottle-fed infants (short-term exposure).’
(WHO 2008) Additionally, in two recent Dutch reports on ‘acid rain’,
with reference to two publications only, nitrate is described as carcino-
genic through the formation of N-nitroso compounds (De Vries 2008;
Buijsman et al. 2010). This insubstantial rendering of nitrate toxicology in
both reports makes for biased conclusions at least, exacerbated by the
absence of a discussion of nitrate physiology we will touch on below.
Indeed, despite persistent regulatory and scientific focus on the risks
of exposure to nitrate, the pendulum swung back as a result of new sci-
entific perspectives once NO was discovered to be a major physiological
chemical component (Furchgott and Zawadzki 1980; Radomski et al.
1987; Marletta et al. 1988; Knowles et al. 1989; Moncada et al. 1991;
Schmidt and Walter 1994; Richardson et al. 2002; Weseler and Bast 2010).
This discovery created and creates a multifaceted image on the role of
nitrate, but also nitrite, in human physiology. NO production has been
shown to be vital to maintain normal blood circulation and defence
against infection (See e.g.: McKnight et al. 1997; McKnight et al. 1999).
Nitric oxide, subsequently, is oxidised from nitrite to nitrate, which is con-
served by the kidneys and concentrated in the saliva.
The discovery of NO as a vital physiological chemical explains the
common knowledge that mammals produce nitrate de novo. Mayerhofer
already observed this already in 1913 (Mayerhofer 1913; see further:
Catel and Tunger 1933). Infections yield the most noticeable instance of
nitrate-biosynthesis, explaining methaemoglobinaemia as a result of
intestinal infections that reduce nitrate to deleterious nitrite, and not
exposure to exogenous nitrate as such (Cornblath and Hartmann 1948;
see further: L’hirondel et al. 2006).4
Connecting Toxicology and Human Health
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Despite these developing physiological insights, the entero-salivary
circulation of nitrate has long been puzzling –the risk of gastro-intestinal
cancers seemed to be the consequence of this mammalian nitrate circu-
lation. After ingestion, nitrate is rapidly and effectively absorbed from the
gastrointestinal tract into the bloodstream, where it mixes with the
endogenously synthesised nitrate. Anaerobic bacteria in the oral cavity
reduce salivary nitrate to nitrite, enhancing the gastric production of N-
nitrosamines, a class of rodent carcinogens that might be detrimental to
human health.
However, despite extensive research over the past 50 years, the link, if
any, between commensal bacteria, nitrate and human gastric cancer is
still up in the air. Indeed, despite the reality of NOC-formation, cohort
studies of fertiliser workers (several hundreds or several thousands) pro-
fessionally exposed to nitrate concentrations higher than the general
public showed no increased risk of gastric cancer (See e.g.: Al-Dabbagh et
al. 1986; Hagmar et al. 1991; Fandrem et al. 1993). In fact, there is increas-
ing evidence that the nitrite that is formed in the mouth from nitrate can
be used by the host to form biologically functional nitrogen oxides
(including NO) that are important for gastro-intestinal host-defence
against pathogenic micro-organism (Duncan et al. 1997; Larauche et al.
2003; Gladwin et al. 2005) and for the maintenance of normal physiolog-
ical homeostasis in the stomach and elsewhere (Lundberg et al. 2004).
This pathway for the generation of reactive nitrogen intermediates in
mammals complements the endogenous production of these intermedi-
ates by nitric oxide synthase.
Moreover, the pendulum swing does not seem to be at its full ampli-
tude. Sodium nitrate supplementation has been reported to reduce the
O2-cost of sub-maximal exercise in humans, for instance (Bailey et al.
2009; see further: Larsen et al. 2011). Also, the dietary provision of
nitrates and nitrites from vegetables and fruit may contribute the lower-
ing of blood pressure (See e.g.: Hord, et al. 2009; Lundberg et al. 2011;
Carlström et al. 2011). The nitrate–nitrite–NO pathway is boosted by
exogenous administration of nitrate/nitrite and this seems to have
important therapeutic as well as nutritional implications: cytoprotection
of ischemia–reperfusion injury, including myocardial infarction, stroke,
liver and kidney ischemia as well as chronic limb ischemia have been
observed in animal models (Lundberg and Weitzberg 2010; see further:
Lundberg et al. 2009). If shown to be on target by additional research,
these effects will continue to alter the image nitrate.
J. C. Hanekamp and others
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4 Sattelmacher -in a famous world-wide survey- and Simon et al. -in a survey of German
hospitals- have reviewed the relation between nitrate concentrations in drinking water and the
relative number of infantile methaemoglobinaemia cases. Both reviews show that the majority
of cases are reported above a nitrate concentration of 100 mg NO3
-/l. Sattelmacher 1962;
Simon et al. 1964).
8
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 2, Art. 4
https://scholarworks.umass.edu/dose_response/vol10/iss2/4
The nitrate example gives ample insight into the conundrum we try
to address here. First, the knowledge that a certain compound by itself,
or through biotransformation, is shown to be a rodent-carcinogen is as
such an ineffectual statement (Ames and Gold 1990; Gold et al. 2001).
Indeed, the knowledge gathered in experimental settings was offset by
epidemiological knowledge that showed no increased risk for gastro-
intestinal cancers at exposure levels higher than normal. To be sure, gath-
ering epidemiological data is not always easy or possible. Nitrate perhaps
is the exception to the rule considering its ubiquitous nature and the
opportunity to research exposure levels in humans beyond the normal
levels found amongst the average populace (Al-Dabbagh et al. 1986;
Hagmar et al. 1991; Fandrem et al. 1993).
Secondly, the scrutinised compound might be part of a system that is
not solely toxicological. Nitrate is part of a larger physiological whole that
we are now uncovering. This has led to starling new insights, whereby
infant methaemoglobinaemia is to be understood as a runaway physio-
logical response to infections that Hegesh and Shiloah already reported
in 1982 (Hegesh and Shiloah 1982). Then again, in toxicology many com-
pounds are researched that are not regarded as part of the human phys-
iology as nitrate and nitrite are –dioxins, PCBs, pesticides- whereby any
exposure is regarded as detrimental only to the organism.
However, hormesis expands on the physiological notion we briefly
developed for nitrate: any chemical-exposure is characterised within the
boundaries of risks and benefits depending on dose, dose-spacing, and
duration of exposure. This is an important notion on multiple levels we
will discuss further at the end of this contribution. First, we will go to the
next example that discusses the multifaceted history of chloramphenicol.
EXAMPLE 2 – CHLORAMPHENICOL
With the discovery of penicillin in 1928 by Alexander Fleming, the
human potential to tackle bacterial infections in both humans and ani-
mals grew immeasurably. Penicillin is made by a fungus (Penicillium nota-
tum) yet most antibiotics we now know today are derived from
Actinomycetes, nature’s topmost bacterial antibiotic producers. Not only do
they produce antibiotics in a huge variety, they also produce chemicals
that kill fungi, parasitic worms and even insects. Many other pharmaceu-
ticals, such as anti-tumour agents and immuno-suppressants, are also
derived from the Actinomycetes. The antibiotics industry is valued at
roughly $ 25 billion per year, underscoring the relevance of the knowl-
edge of these bacteria, not to mention the benefits that are incurred by
the human and animal recipients of antibiotics (Hopwood 2007).
The Streptomycetes, belonging to the Actinomycetes, account for well
over half of these commercially and therapeutically significant antibiotics,
which are produced by means of complex ‘secondary metabolic’ pathways
Connecting Toxicology and Human Health
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(Walsh 2003). Streptomycetes therefore are the most important source of
antibiotics for medical, veterinary and agricultural use. Streptomycetes are
a group of gram-positive filamentous bacteria, ubiquitous soil-bacteria.
They are among the most numerous and ubiquitous soil bacteria adapted
to the utilization of plant remains and are key in this environment because
of their broad potential of metabolic processes and biotransformations
(Hanekamp 2010). These include degradation of the insoluble remains of
other organisms making streptomycetes imperative organisms in carbon
recycling (Bentley et al. 2002). In passing, streptomycetes are members of
the same taxonomic order as the causative agents of tuberculosis and lep-
rosy (Mycobacterium tuberculosis and M. leprae).
While secondary metabolites must in all likelihood confer an adaptive
advantage, the roles of most are not fully understood. Antibiotics give a
competitive advantage compared to other ground-dwelling micro-organ-
isms that need to tap into the same biomass as nutrition. To give a very
limited indication of the different antibiotics produced by
Streptomycetes and their close relatives, we give some examples of med-
ically important antibiotics in Table 1 (Chater 2006).
Chloramphenicol (or chloromycetin as it was called initially) was first
isolated for therapeutic purposes by Ehrlich et al. in 1947 (Ehrlich et al.
1947; see in the same edition: Smadel and Jackson 1947). A year after its
isolation it proved to be quite effective against typhoid fever (Patel et al.
1949). Apart from being used as human medication, chloramphenicol
also has an extensive track record in animal food production.
Chloramphenicol is an efficacious therapeutic agent that has been wide-
ly used in fish farms (Baticados et al. 1990; Morii et al. 2003). Despite its
successful medical and veterinary history, chloramphenicol fell out of
favour in the medical field because of the side-effect aplastic anaemia
during therapy, a form of anaemia in which the bone marrow ceases to
produce sufficient red and white blood cells. Its incidence is extremely
rare but fatal (Benestad 1979).
The minimum dose of chloramphenicol associated with the develop-
ment of aplastic anaemia is unknown. The aplastic anaemia incidence
estimated by the JECFA (Joint FAO/WHO Expert Committee on Food
J. C. Hanekamp and others
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TABLE 1. Antibiotic-producing organisms, antibiotics, and targeted diseases. 
Target disease Antibiotic Producing organism
Methicillin-resistant Staphylococcus aureus (MRSA) Vancomycin Amycolatopsis 
(Streptomyces) orientalis
Typhoid (Salmonella enterica serovar Typhi.) Chloramphenicol Streptomyces venezuelae
Pathogens with transmissible penicillin resistance Clavulanic acid Streptomyces clavuligerus
TB and leprosy Rifampicin Amycolatopsis 
(Streptomyces) mediterranei
Cancer Daunomycin Streptomyces clavuligerus
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Additives) is in the order of 1.5 cases per million people per year (IPCS-
INCHEM, 1994). Only about 15 per cent of the total number of cases was
associated with drug treatment, and among those chloramphenicol was
not a major contributor. These data roughly give an overall incidence of
therapeutic chloramphenicol-associated aplastic anaemia in humans of
less than one case per 10 million per year. The ophthalmic use of chlo-
ramphenicol represents the lowest therapeutic dose in the medical field.
Epidemiological data relating to the ophthalmic use of chloramphenicol
in humans suggest that this form of administration is unlikely to be con-
nected with aplastic anaemia (IPCS-INCHEM, 2005). Because of the lim-
ited data available, however, it is unfeasible to determine a proper dose-
response model for aplastic anaemia (IPCS-INCHEM, 1988).
Apart from this serious medical side effect, chloramphenicol is
regarded as genotoxic and carcinogenic (Shu et al. 1987), thereby receiv-
ing an unfavourable appraisal in the veterinary field. Even so, the avail-
able data on the genotoxicity show mainly negative results in bacterial sys-
tems and mixed results in mammalian systems. It was concluded that
chloramphenicol must be considered genotoxic, but only at concentra-
tions about 25 times higher than those occurring in patients treated with
the highest therapeutic dosages (Martelli et al. 1991). Chloramphenicol is
categorised by the IARC (the International Agency for Research on
Cancer) as probably carcinogenic in humans; group 2A (IARC 1997).
No tolerable daily intake (TDI) could be established for chloram-
phenicol due to the lack of scientific information to assess its carcino-
genicity and effects on reproduction, and genotoxic activity (IPCS-
INCHEM, 1994). As a result, no maximum residue level (MRL) could be
established for chloramphenicol. For that reason it is not allowed in food-
producing animals, including aquaculture. In Europe, zero tolerance lev-
els were in force for compounds without a MRL, meaning that banned
chemicals should not be detected in food products at all, regardless of
concentrations. This is to all intents and purposes the regulatory use of
the linear no-threshold model (LNT): when dealing with genotoxic car-
cinogens the ‘no-dose no-disease’ approach is regarded as the safest reg-
ulatory route (Calabrese and Baldwin 2003; despite the fact that it depicts
a non-existing physico-chemical reality barred by the Second Law of
Thermodynamics). Concisely, the explicit goal of zero tolerance is not
risk-based but precaution-based, as the absence of a MRL is from a regula-
tory point of view translated as ‘dangerous at any dose’ (Hanekamp and
Bast 2007).
Zero tolerance, as a result of increasing analytical capabilities of
detection, has created immense problems especially for imported aqua-
culture products, the epitome of which was the trade-dispute between the
European Union and some Asian countries over the parts-per-billion-
presence of chloramphenicol in shrimp during the first half of the 2000s
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(Hanekamp et al. 2003; Hanekamp and Wijnands 2004; Annex IV of
Council Regulation (EEC) No. 2377/90). The zero-tolerance policy was
replaced only in 2009 by MRPLs (Minimum Required Performance
Limit) as targets for regulatory action levels of concern for banned antibi-
otics (Regulation (EC) No 470/2009). The fallacy of zero-tolerance that,
however, is not resolved in this MRPL-approach is on the one hand related
to the misconceived idea that an unambiguous causal link can be made
between the detection of some banned compound and illegality in food
production, and on the other hand connected to the idea that some form
of risk is incurred when exposed to low-level concentrations of chemicals
such as chloramphenicol. Concerning the former, and in line with our
own findings (Hanekamp et al. 2003), chloramphenicol has recently been
found as a natural component in plant material, which is used as animal
feed through which it is transferred to animal tissue (Berendsen et al.
2010; see our response: Hanekamp et al. 2011). With regards to the latter,
that is the core of this contribution.
When considering the difference between therapeutic exposure –as a
result of which aplastic anaemia has been observed- and the much lower
exposure to food residues, it seems clear that chloramphenicol is unlikely
to present a substantial risk, if at all, even assuming a linear dose-response
correlation. The food residue exposure levels shown in Figure 2 are taken
from the RIVM study (Dutch National Institute for Public Health and
Environment) on chloramphenicol in shrimp (Janssen et al. 2001).
The food exposure was calculated from the ‘reasonable worst-case’
scenario of a weekly shrimp consumption of 8.4 g contaminated with
10µg chloramphenicol per kg shrimp. The RIVM, using the LNT model,
estimated the cancer risk as a result of the consumption of shrimp con-
taining chloramphenicol as negligible. The concentrations in imported
shrimp varied roughly between 1 and 10 ppb (1 to 10 µg/kg product).
The estimated ‘reasonable worst-case risk’ as a result of eating shrimp
containing chloramphenicol is lower than the MTR-level (being an
added risk of disease or death of 1 individual in a population of 1 million
usually put forward as 1:106) by at least a factor of 5000. Despite this aus-
picious risk-based analysis, chloramphenicol nonetheless is a suspect
compound for which a ban is kept in place in the veterinary field.
The pendulum swing has seemingly frozen. What once began as a suc-
cessful antibiotic in the late 1940s curing diseases such as typhoid fever
and being effective in animal rearing and aquaculture, has now been dis-
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carded and banned for fear of its carcinogenic and genotoxic potential at
any exposure level. However, apart from the continued efficacy of chlo-
ramphenicol in human medicine, the potential of chloramphenicol in
aquaculture makes for an interesting conundrum in view of the rising
food-requirements in the world (Selvin and Lipton 2003). In terms of the
consumption of animal protein, aquaculture clearly seems a way forward.
Indeed, ‘future increases in per capita fish consumption will depend on
the availability of fishery products. With capture fisheries production
stagnating, major increases in fish food production are forecast to come
from aquaculture. Taking into account the population forecast, an addi-
tional 27 million tonnes of production will be needed to maintain the
present level of per capita consumption in 2030.’ (FAO 2010, p. 69).
The UK Government Office for Science, in their final report
‘Foresight The Future of Food and Farming’, observes that the demand
for fish ‘is expected to increase substantially, at least in line with other
protein foods, and particularly in parts of east and south Asia. The major-
ity of this extra demand will need to be met by further expansion of aqua-
culture, which will have significant consequences for the management of
aquatic habitats and for the supply of feed resources’. Clearly, ‘[a]qua-
culture, which will have a major role to play in meeting the supply and
resource challenges ahead, will need to produce more with increased sus-
tainability.’ (The Government Office for Science 2011, p. 14 and 35).
In light of this point, it is ironic to note that chloramphenicol seems
a very efficacious pharmacon against B. dendrobatidis, a chytrid fungus, of
amphibians such as frogs (Schloegel et al. 2010. Archey’s frog Leiopelma
archeyi, for instance, is a critically endangered New Zealand endemic
species to a certain extent affected by chytridiomycosis (Bishop et al.
2009). The discovery of the emerging infectious disease –chytridiomyco-
sis- in wild populations of frogs raised concern that this disease may drive
some frog species and other amphibians to extinction. It is interesting to
note a renewed interest in chloramphenicol, not only because frogs are
human food, but also because biodiversity is involved. This emerging
issue crosses the borders of food production and biodiversity, showing
that the pendulum-swing of risks and benefits never ceases.
But that is only part of the story. With this renewed interest in chlo-
ramphenicol in food production, the genotoxic and carcinogenic conun-
drum has not gone away and cannot be resolved within the old context
of the LNT model, which assumes toxicity at any dose other than zero. In
contrast, hormesis accounts for both sides of the pendulum swing, which
the LNT model cannot. With hormesis at the basis for analyzing the risks
from low-level exposures, the pendulum swing can be understood as
more or less artificially created by our regulatory efforts to reduce chem-
icals exposure. In order to assess the risks and benefits of chlorampheni-
col –in terms of its use in food production such as aquaculture and the
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resulting exposure to humans through the produced foods- hormesis
seems a way forward. This we will look into subsequently.
DISCUSSION AND CONCLUSION
The two examples we have discussed above demonstrate that risks and
benefits are an integral part of chemical exposures. This holds for both
nitrate and chloramphenicol. Interestingly, despite the enormous
advances in research, regulatory efforts to diminish nitrate exposures
from food are still in place. Nitrate stands model for a real-life experi-
mentation in which idiosyncratic impetuses –e.g. the work of Comly and
on nitrosamines- were understood as capturing the full toxicological pro-
file. As the WHO states in its Guidelines for Drinking-Water Quality: ‘Most
chemicals arising in drinking-water are of health concern only after
extended exposure of years, rather than months. The principal exception
is nitrate’ (WHO 2008, p. 145). The WHO here refers to methaemoglo-
binaemia as an acute toxicological response in young children exposed to
nitrate. Yet, the balance of the evidence does not point to this conclusion
at all, and neither does it point to cancer. In the final analysis, nitrate and
nitrite research is in the upswing towards their overall benefits, which
remain unrecognised by regulatory science and its policy spin-offs. The
two Dutch reports referred to above do not even hint at the novel finds
we touched on above only briefly, exposing the regulatory bias to an out-
dated risks-only understanding of chemical exposures.
In sharp contrast to nitrate, chloramphenicol and many other chem-
icals are not an inherent part of our physiology. Those and many other
chemicals are regarded as xenobiotic, that is either as compounds foreign
to human physiology or, more often, regarded as wholly artificial and
thereby as alien. Yet, we are constantly exposed to a myriad of chemical
compounds, primarily as part of the chemical food-matrix. Dividing this
bulk of different chemicals between ‘innate’ and ‘foreign’, a proxy to
‘natural’ and ‘man-made’ or ‘good’ and ‘bad’, seems not only an impos-
sible but also a fruitless task. The biochemistry of animals, plants or even
entire biogeochemical cycles is immeasurably more intricate than the
mere allocation of marker molecules for the legal control of certain
chemicals (antibiotics such as chloramphenicol, pesticides, pollutants
such as dioxins) suggests. Put differently, the set of man-made chemicals
partly or wholly overlaps with the much bigger set of natural chemicals
produced in the biogeosphere.
It is questionable that our immense complex biogeochemical reality
–animals, plants, bacteria, fungi but also geochemical processes- can be
forced into a reductionist scientific and legal construct put in place to
protect the public against ‘toxic’ chemicals of man-made origin in food
by ‘simply’ lessening their presence in the environment and our foods. It
is not an exaggeration to state that most, if not all, (bio)organic mole-
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cules that can be identified as artificial will have their natural counter-
parts. A famous example is the group of chemicals known as halogenated
hydrocarbons, of which the chlorinated chemical compounds are the
most ‘notorious.’5
Chlorine is one of the most abundant elements on the surface of the
earth. It was –and still is by most- widely believed that all chlorinated
organic molecules are xenobiotic (that is man-made chemicals), that
chlorine does not participate in biological processes at all and that it is
present in the environment only as the relatively benign chloride anion
Cl– (the anion of table salt NaCl). In the 1990s a controversy arose in the
United States regarding an environmentalist call to ban or phase out the
production and use of chlorinated organic chemicals, inorganic chlorine
bleaches, and elemental chlorine (Thornton 1991). The argument for a
chlorine ban was carried by the notion that the organochlorine com-
pounds are foreign to nature (Cap 1996; Lewis and Chepesiuk 1995.
However, it has become increasingly clear that organohalogens are
ubiquitously produced in nature. Some of these compounds are pro-
duced in amounts that dwarf human production. Other compounds are
produced in small quantities. The sum total of different organohalogens
is staggering –more than 5000 different natural organic halogen com-
pounds, from the very simple to the very complex, have been identified
so far- and come from widely diverging sources: marine, terrestrial bio-
genic, terrestrial abiotic, biomass combustion (natural and anthro-
pogenic), and volcanoes (Öberg 2002; Gribble 2010). Paradoxically, ana-
lytical chemistry with its increasing detection capabilities uncovered the
naturalness of so many organohalogens and other chemicals regarded
and regulated as man-made. Thus, the regulatory dependence on analyt-
ical chemistry has greatly confounded the regulatory power to control
food-safety solely on the presence of this or that chemical, instead of
focussing on toxicological relevance.
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unrelated to human physiology.
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Taking the above facts together, we should go beyond the artificial
pendulum swing that characterises current research into the mechanism
of organisms (humans) interacting with its chemical environment.
Hormesis redefines the concept of ‘pollution’ or ‘contamination’ (Cross
2001). Chemical substances –innate of foreign- are not ‘bad’ or ‘good’,
‘natural’ or ‘artificial’. They are or can be both, depending on sources,
exposure levels, exposure duration, and adaptive responses from the
exposed organisms (Wiener 2001). Hormesis, the moderate overcom-
pensation to a chemical (or radiological) perturbation of the homeosta-
sis of an organism in order to re-establish the homeostasis, explicates the
adaptive nature, the biological plasticity, of the overall process (Calabrese
and Baldwin 2001). That should be on the scientific-toxicological agenda
when considering chemical food-safety and the health-consequences of
low-level chemical exposure, in line with definitions of human health that
stress adaptiveness, rather than utopian definitions such as the current
WHO characterization of health (Garner 1979; Larson 1999):6 (i) ‘states
of health or disease are the expressions of the success or failure experi-
enced by the organism in its efforts to respond adaptively to environ-
mental challenges’ (Dubos 1979, 1965); ‘Health consists in the capacity
of the organism to maintain a balance in which it may be reasonably free
of undue pain, discomfort, disability or limitation of action including
social capacity’ (Goldsmith 1972; see further Selye, 1975).
Hormesis requires us to look at toxicological research in a different
manner. Toxicity testing should be functional towards real-life scenarios
of exposure to chemicals through the food-matrix as opposed to the stan-
dard reductionist endpoints that usually are remote proxies for human
health. First, in order to close the gap between models and real-life sce-
narios the use of fully functional human primary cell-lines seem a way for-
ward. Especially, lung epithelial, intestinal epithelial cells and blood ves-
sel endothelial cells are of interest as these cells are part of human organs
of first contact prone to major toxic risks (i.e. highest concentration of
exposure). Also, biotransformation/elimination are processes found in
hepatocytes and kidney cells, which makes them sensitive to toxicity.
Secondly, markers of toxicity should reflect organ specific functionalities.
Lung epithelial cells could be tested for their integrity as barrier cells and
for release of factors that modulate the lung smooth muscle. Intestinal
epithelial cells could be investigated for their integrity characteristics on
barrier function and blood vessel endothelial cells for release of blood
vessel smooth muscle cell modulating factors (as the release of NO).
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Hepatocytes could be tested for their functionality of metabolism of
xeno- and endobiotics; renal cells for their transporter function.
These are just a few examples that can and will be added to in view of
the increasing knowledgebase in toxicology, pharmacology and physiolo-
gy (NRC 2007). What is important to realise is that that a search for a
‘toxic free society’ is not only pointless, but is also derived from a myopic
view of human toxicology. The biological plasticity of human physiology
as described by hormesis, the complexity of food chemistry, and the over-
estimation to add, in terms of diversity, to the already gargantuan set of
natural chemicals in the biogeosphere, underscores this myopism.
In order to bridge the chasm between toxicology and human health
with respect to low-level chemical exposures, firstly, the proxy of detec-
tion (e.g. in food) should be abandoned in favour of toxicological rele-
vance of (low-level) exposure. Secondly, organ specific functionalities
should be part of toxicological research next to traditional endpoint
research. Thirdly, and perhaps most importantly, the axiomatic linear
extrapolative models in toxicology should be abandoned for the empiri-
cal hormetic dose-response model. Hormesis is focussed on the low-level
exposure effects particularly important in food chemistry, captures both
the risks and benefits of chemicals, and removes the counterproductive
and artificial distinction between ‘natural’ and ‘man-made’ chemicals
ironically exposed by state-of-the-art analytical chemistry. Fourthly, in
view of these developments, it seems highly likely that REACH will be out-
dated before it even gets underway, making it a very costly and ultimate-
ly an unwarranted effort (Hartung and Rovinda 2009).
In the final analysis, the words of Thomas Nagel seem to capture a
pointed reflection on the reductionist potential and its limits: ‘... for
objectivity is both underrated and overrated, sometimes by the same per-
sons. It is underrated by those who don’t regard it as a method of under-
standing the world as it is in itself. It is overrated by those who believe it
can provide a complete view of the world on its own, replacing the sub-
jective views from which it has developed. These errors are connected:
they both stem from an insufficiently robust sense of reality and of its
independence of any particular form of human understanding.’ (Nagel
1986, p. 4).
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